ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
Vector Science & Therapeutics (TSXV: PAIN) began peptide production as the first suite at its LyoGenesis manufacturing facility came online, according to a company announcement. The milestone marks operational startup for the new production capacity.
Tap to vote and see what everyone thinks.
Summary by ByteBrief